人參 Panax Ginseng

INT-panax-ginseng-001 3 個適應症被研究
C 2 D 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:neutral
FDA ceased to evaluate this notice
來源 ↗
L4b · EU EFSA
立場:cautious
L4c · UK NHS
立場:cautious
Herbal medicines are not available on the NHS. ... Herbal medicines are not tested in the same way as standard medicines to see how well they work. ... Always check first with a pharmacist before taking a herbal medicine, if you're already taking other medicine. ... Only use herbal products with a traditional herbal registration (THR) mark and a product code from the Medicines and Healthcare pr…
來源 ↗
L4d · TW TFDA / 衛福部
立場:neutral
人參為五加科植物人參(Panax ginseng C.A. Meyer)的乾燥根。人參茶包所含有之原料人參,應符合中藥藥材污穢物質限量之規定,總重金屬限量為20ppm、砷2ppm、總BHC 0.9ppm、總DDT 1.0ppm及PCNB 1.0ppm。
來源 ↗
L4e · WHO
立場:supportive
Radix Ginseng [the dried root of Panax ginseng C.A. Meyer] is used as a prophylactic and restorative agent for enhancement of mental and physical capacities, in cases of weakness, exhaustion, tiredness, and loss of concentration, and during convalescence. The recommended dosage is 0.5-2 g of dried root per day; there are no contraindications regarding ginseng.
來源 ↗

市場與行銷 (L10)

L10a · TW Market Channels
正官庄高麗蔘精植物性膠囊 60顆/罐
L10b · TW Legal Identity (TFDA)
人參、當歸等常見的藥膳料理中藥材,雖不在新清單中
L10c · TW Community (PTT/Dcard/Mobile01)
喝一條晚上都睡不著,整個有補